Clinical Experience with Minocycline and Rifampin-Impregnated Central Venous Catheters in Bone Marrow Transplantation Recipients: Efficacy and Low Risk of Developing Staphylococcal Resistance

Infection Control and Hospital Epidemiology

Volumn 24, Issue 12, 2003, Pages 961-963

  Chatzinikolaou, Ioannis ^a,c   Hanna, Hend ^a   Graviss, Linda ^a   Chaiban, Gassan ^a   Perego, Cheryl ^a   Arbuckle, Rebecca ^a   Champlin, Richard ^a   Darouiche, Rabih ^b   Samonis, George ^c   Raad, Issam ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE; RIFAMPICIN; TETRACYCLINE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BONE MARROW TRANSPLANTATION; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG COATING; DRUG EFFICACY; DRUG USE; FEMALE; FOLLOW UP; HUMAN; INFECTION RISK; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MATERIAL COATING; NEUTROPENIA; NONHUMAN; RECIPIENT; RETROSPECTIVE STUDY; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTITUBERCULAR; BONE MARROW TRANSPLANTATION; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; COHORT STUDIES; CROSS INFECTION; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE; FEMALE; HUMANS; INFECTION CONTROL; LEUKEMIA; MALE; MIDDLE AGED; MINOCYCLINE; NEUTROPENIA; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; TEXAS;

EID: 9144231425     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502167     Document Type: Article

References (10)

1. Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevenfion of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann Intern Med 1997;127:267-274.
2. Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999;340:1-8.
3. Hanna H, Benjamin RS, Chatzinikolaou I, et al. The role of long-term silicone central venous catheters impregnated with rifampin and minocycline (S-CVC-RM) in preventing catheter-related infections: a prospective randomized study. Presented at the 38th Annual Meeting of the American Society of Clinical Oncology; May 18-21, 2002; Orlando, FL.
4. Tambe SM, Sampath L, Modak SM. In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemother 2001;47:589-598.
5. Sampath LA, Tambe SM, Modak SM. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect Control Hosp Epidemiol 2001;22:640-646.
6. Benezra D, Kiehn TE, Gold JW, Brown AE, Turnbull AD, Armstrong D. Prospective study of infections in indwelling central venous catheters using quantitative blood cultures. Am J Med 1988;85:495-498.
7. Darouiche RO, Raad II, Bodey GP, Musher DM. Antibiotic susceptibility of staphylococcal isolates from patients with vascular catheter-related bacteremia: potential role of the combination of minocycline and rifampin. Int J Antimicrob Agents 1995;6:31-36.
8. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000.
9. Herwaldt LA, Geiss M, Kao C, Pfaller MA. The positive predictive value of isolating coagulase-negative staphylococci from blood cultures. Clin Infect Dis 1996;22:14-20.
10. Hanna HA, Raad I. Blood products: a significant risk factor for long-term catheter-related bloodstream infections in cancer patients. Infect Control Hosp Epidemiol 2001;22:165-166.